• Kitsap Respiratory Illness Report: April 30 – May 27

    Kitsap Respiratory Illness Report: April 30 – May 27

    , , , , , , , , ,

    Click here to access weeks 18 through 21 of the Kitsap Respiratory Illness Report. Summary: Local influenza activity is currently low, with 11 positive influenza tests in the past four weeks (1,733 cumulative (13% of total tested) since 10/2/2022). RSV activity is currently low, with 3 positive RSV tests in the past four weeks (498 since Kitsap Respiratory Illness Report: April 30 – May 27

    Read more

  • Meningococcal Disease Fact Sheet

    Meningococcal Disease Fact Sheet

    Meningococcal disease is a sudden, severe illness caused by the bacterium Neisseria meningitidis. The disease manifests most commonly as meningitis and/or meningococcemia, but may also cause pneumonia, arthritis or pericarditis. The symptoms include sudden high fever, chills, severe headache, stiff neck and back, nausea, vomiting, purpural rash, decreased level of consciousness, difficulty breathing and seizures. Meningococcal Disease Fact Sheet

    Read more

  • Perinatal Hepatitis B

    Perinatal Hepatitis B

    Guidelines for Prenatal Care Screen every pregnant woman for HBsAg early in each pregnancy according to Centers for Disease Control and Prevention and American College of Obstetricians and Gynecologists recommendations. HbsAg testing should be repeated late in pregnancy if the woman is HBsAg negative and is at high risk of hepatitis B infection (e.g., injection Perinatal Hepatitis B

    Read more

  • Hepatitis B Immunization and Healthcare Workers

    Hepatitis B Immunization and Healthcare Workers

    Healthcare Worker Immunization Pre-exposure evaluation for healthcare personnel previously vaccinated with complete, ≥ three dose hepatitis B vaccine series who have not had post-vaccination serologic testing* Source: CDC—MMWR December 20, 2013. * Should be performed one to two months after the last dose of vaccine using a quantitative method that allows detection of the protective Hepatitis B Immunization and Healthcare Workers

    Read more

  • Latent Tuberculosis Infection Treatment Guidelines

    Latent Tuberculosis Infection Treatment Guidelines

    High-Priority Candidates for Latent Treatment Infection (LTBI) Treatment Positive QuantiFERON-TB Gold (QFT) (>0.35 IU) Tuberculosis Skin Test (TST) ≥5 mm HIV-positive people. Recent contacts of person with infectious tuberculosis (TB). People with fibrotic changes on chest x-ray (CXR) suggestive of previous TB; or inadequate treatment. People with organ transplants or immunosuppression therapy. TST ≥10 mm Latent Tuberculosis Infection Treatment Guidelines

    Read more

  • Infection Control Guidelines

    Infection Control Guidelines

    Standard, Contact, Airborne and Droplet Precautions Standard Precaution When to Use Standard Precautions During all patient encounters—prevents the spread of bloodborne pathogens such as HIV, Hepatitis B and Hepatitis C. Reason to Use Standard Precautions Protects the healthcare worker from patient’s potentially contaminated body fluids and prevents the spread of disease to others. Components of Infection Control Guidelines

    Read more

  • Controlling Norovirus

    Controlling Norovirus

    You may hear norovirus called “the stomach flu.” Some viral illnesses that cause vomiting and diarrhea are caused by norovirus. You can become infected with norovirus many times in your life. Norovirus Is very contagious. Norovirus can spread quickly in places like daycare centers, nursing homes, schools, restaurants and cruise ships. Causes diarrhea and vomiting, Controlling Norovirus

    Read more

  • Tdap and Pregnancy

    Tdap and Pregnancy

    Pertussis is a serious disease for young infants. Pertussis epidemics occur in the United States every three to five years. Even though we have a vaccine, pertussis is a common infectious disease. There are 10,000 to 40,000 cases and 10 to 20 deaths per year.[1] Pertussis is most serious in infants younger than six months. Tdap and Pregnancy

    Read more

  • Chlamydia Diagnosis Follow-up

    Chlamydia Diagnosis Follow-up

    Provider Checklist Patient treatment for chlamydia is not complete without partner treatment. After receiving a positive chlamydia result, check the following steps to help stop the spread of chlamydia and to protect your patient from reinfection: Provide patient education on essential points: Take medications as prescribed. Do not have sex for seven days after treatment, Chlamydia Diagnosis Follow-up

    Read more

  • Hand Hygiene in Healthcare Settings

    Hand Hygiene in Healthcare Settings

    What is hand hygiene? Hand hygiene refers to the use of hand washing with soap and water or alcohol hand sanitizer (60% alcohol or greater) in order to reduce infection rates, reduce transmission of antimicrobial resistant organisms and stop outbreaks of communicable disease. Why is hand hygiene important? Clean hands are the single most important Hand Hygiene in Healthcare Settings

    Read more

  • Environmental Cleaning

    Environmental Cleaning

    Quick Reference: Environmental Cleaning How to clean equipment and surfaces, when to clean, what to use Visibly Soiled surfaces: Scrub the surface with a cleaner/detergent or a disinfectant that contains a cleaner/detergent. Wear gloves! May need to rinse (check label). Will NOT need to rinse if using a wipe that contains both a detergent and Environmental Cleaning

    Read more

  • Bloodborne Pathogens

    Bloodborne Pathogens


    Post Exposure Prophylaxis and Training Resources National Clinicians’ Post-Exposure Prophylaxis (PEPline) Hotline (888) HIV-4911 Exposure to bloodborne pathogens can present serious risks to healthcare providers. Prompt post-exposure treatment for HIV and hepatitis B virus can be effective, but because each exposure case is unique, determining who should receive prophylaxis and which drugs are most appropriate Bloodborne Pathogens

    Read more

  • Tuberculosis FAQ

    Tuberculosis FAQ

    Tuberculosis Screening Tests Tuberculosis skin test (TST) (formerly known as PPD) Tubersol or Aplisol can be purchased through your medical supply chain. Ten or 50 dose vials, once opened must be used within 28 days. Requires skill to apply intradermally and read results properly. Patient must have two office visits. Sensitive test and inexpensive. See Tuberculosis FAQ

    Read more